Gå direkt till huvudinnehållet

Neutropeni

Senast uppdaterad: Publicerad:
Sakkunnig:


  1. Pizzo PA. Fever in immunocompromised patients. N Engl J Med 1999; 341: 893. PubMed  
  2. Statens helsetilsyn. Bruk av antibiotika i sykehus. Oslo: Elanders Publishing AS, 2001.
  3. Wiger K, Høiby EA, Wathne K-O. Infeksjoner hos immunsupprimerte barn. Tidsskr Nor Lægeforen 2005; 125: 1168-72. PubMed  
  4. Zeidler C, Boxer L, Dale D, Freedman MH, Kinsey S, Welte K. Managemant of Kostmann Syndrome in the G-CSF era. Br J Haematol 2000; 109: 490 - 5. PubMed  
  5. Welte K, Boxer LA. Severe chronic neutropenia: pathophysiology and therapy. Semin Hematol 1997; 34: 267 - 78. PubMed  
  6. Cullen M, Steven N, Billingham L et al. Antibacterial propylaxis after chemotherapy for solid tumors and lymphomas. N Engl J Med 2005; 353: 988-98. New England Journal of Medicine  
  7. Bucaneve G, Micozzi A, Menichetti F et al. Levofloxacin to prevent bacterial infections in patients with cancer and neutropenia. N Engl J Med 2005; 353: 977-87. New England Journal of Medicine  
  8. Freedman MH. Safety of long-term administration of granulocyte colony-stimulating factor for severe chronic neutropenia. Curr Opin Hematol 1997; 4: 217 - 24. PubMed  
  9. Freedman MH. Congenital marrow failure syndromes and malignant hematopoietic transformation. Oncologist 1996; 6: 354 - 60. PubMed  
  10. Paul M, Soares-Weiser K, Grozinsky S, Leibovici L. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia (Cochrane Review). In: The Cochrane Library, Issue 2, 2002. Oxford: Update Software. The Cochrane Library  
  • Honar Cherif, med dr och överläkare, Hematologikliniken, Akademiska sjukhuset, Uppsala

Tidigare sakkunniga

  • Terje Johannessen, professor i allmänmedicin, Institutt for samfunnsmedisinske fag, Norges teknisk-naturvitenskapelige universitet, Trondheim